Immunosuppressive Drug Coverage
Every year, thousands of Americans receive kidney transplants through the Medicare End Stage Renal Disease (ESRD) Program, which also covers dialysis, immunosuppressive drugs and other medically important services. After transplantation patients must take immunosuppressive drugs every day for the life of the transplants to decrease the risk that their bodies will reject the organs. Unfortunately, Medicare only provides 36 months of coverage for these immunosuppressive drugs. After that three-year period, many patients who are no longer eligible for Medicare struggle to find coverage or to purchase the anti-rejection medications themselves. As a result, patients often end-up back on dialysis sooner than they should, increasing both their time on dialysis as well as everyone’s wait for a transplant. Others don’t even apply for the transplant list as they know they can’t afford the drugs and continue on dialysis indefinitely. DPC is working hard to eliminate the current cap on immunosuppressive drug coverage in Medicare.
The Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2019 (H.R. 5534) was recently introduced by Representatives Ron Kind (D-WI) and Michael Burgess (R-TX). This legislation would extend Medicare coverage of immunosuppressant [...]
Dialysis Patient Citizens wants to wish you and your family a Happy Holiday, as well as a safe and healthy New Year. Our offices will be closed for the holidays starting December 23 through January 1. [...]
August 25, 2015 Andrew Slavitt, Acting Administrator Centers for Medicare and Medicaid Services Department of Health and Human Services Hubert H. Humphrey Building 200 Independence Avenue SW Washington, D.C. 20201 Dear Mr. Slavitt, Dialysis [...]
This week President Obama signed the Protecting Access to Medicare Act, which contained some provisions favorable to dialysis patients. The primary purpose of the legislation was to stabilize Medicare payments to physicians, but Congress also [...]
DPC Urges Medicare Agency to Withdraw Proposal That Could Weaken Protections for Transplant Patients
Dialysis Patient Citizens (DPC) weighed in against a Medicare proposal that would complicate some transplant patients’ access to immunosuppressive drugs. Medicare Part D, like other private health plans, uses drug formularies to keep down [...]